XML 82 R67.htm IDEA: XBRL DOCUMENT v3.20.2
Shareholders' Equity - Narrative (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Feb. 29, 2020
USD ($)
shares
Jan. 31, 2020
USD ($)
$ / shares
shares
Mar. 31, 2019
Unit1
$ / shares
shares
Feb. 29, 2020
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sale of Stock [Line Items]                  
Noncontrolling interest compensation expense           $ 1,439 $ 0 $ 1,439 $ 0
Proceeds from sale of common stock         $ 282,833     283,333 303,221
Other offering expenses               $ 2,300 $ 1,150
Number of directors to whom the Company agreed to issue warrants | Unit1       2          
BioShin 2020 Equity Incentive Plan                  
Sale of Stock [Line Items]                  
Requisite service period of award (in years) 3 years                
Minimum                  
Sale of Stock [Line Items]                  
Requisite service period of award (in years)               3 years  
Maximum                  
Sale of Stock [Line Items]                  
Requisite service period of award (in years)               4 years  
Series A preferred shares | Minimum                  
Sale of Stock [Line Items]                  
Preferred shares call and put options execution multiple following change of control 2.5                
Series A preferred shares | Maximum                  
Sale of Stock [Line Items]                  
Preferred shares call and put options execution multiple following change of control 3.5                
BioShin Preferred Shares | Series A preferred shares                  
Sale of Stock [Line Items]                  
Preferred stock issued and sold (in shares) | shares 15,384,613                
Shares issued price per share | $ / shares $ 3.90                
Proceeds from shares issued $ 60,000                
Public Offering                  
Sale of Stock [Line Items]                  
Common stock issued (shares) | shares     4,830,917            
Issuance price per share (in dollars per share) | $ / shares     $ 51.75            
Proceeds from sale of common stock     $ 245,877            
Underwriting discounts and commissions     3,623            
Other offering expenses     $ 500            
Over-Allotment Option                  
Sale of Stock [Line Items]                  
Common stock issued (shares) | shares   724,637              
Proceeds from sale of common stock   $ 36,956              
Underwriting discounts and commissions   $ 543              
Credit Agreement Warrants                  
Sale of Stock [Line Items]                  
Number of securities called by warrants (shares) | shares       107,500          
Exercise price of warrants (in dollars per share) | $ / shares       $ 9.2911